𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rhinorrhea: A common nondopaminergic feature of Parkinson's disease

✍ Scribed by Kelvin L. Chou; Robert A. Koeppe; Nicolaas I. Bohnen


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
629 KB
Volume
26
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


We compared the frequency of rhinorrhea between 34 Parkinson's disease (PD) subjects and 15 normal controls (NC) and explored relationships between rhinorrhea and clinical functions, and degree of nigrostriatal dopaminergic denervation using [ 11 C]dihydrotetrabenazine (DTBZ) brain positron emission tomography imaging. Sixty-eight percent (23 of 34) of PD subjects reported rhinorrhea of any cause compared with 27% (4 of 15) of NC (v 2 5 7.07, P 5 0.008). Rhinorrhea frequency remained higher in the PD group after excluding possible rhinitic etiologies: 35% (12 of 34) of PD versus 7% (1 of 15) of NC (v 2 5 4.38, P 5 0.04). There were no differences in demographics, nigrostriatal dopaminergic denervation, and clinical motor or nonmotor variables between PD subjects with and without rhinorrhea, except that more PD subjects with rhinorrhea complained of lightheadedness (52% vs. 9%, v 2 5 5.85, P 5 0.02). Rhinorrhea is a common nondopaminergic feature of PD, unrelated to olfactory or motor deficits. Further investigations are needed to determine if rhinorrhea correlates with sympathetic denervation or other autonomic symptoms in PD. V


πŸ“œ SIMILAR VOLUMES


Prevalence and clinical features of comm
✍ Yue Huang; Glenda M. Halliday; Himesha Vandebona; George D. Mellick; Frank Masta πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 1 views

## Abstract We determined the prevalence of two common leucine‐rich repeat kinase 2 (LRRK2) gene mutations in Australian patients with Parkinson's disease (PD). Of 830 affected patients, eight were heterozygous for the G2019S mutation, and two were heterozygous for the R1441H (4,322 G > A) mutation

Common variants in Parkinson's disease
✍ Owen A. Ross; Matthew J. Farrer; Ruey-Meei Wu πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 48 KB
Flumazenil, a GABA antagonist, may impro
✍ William G. Ondo; Christine Hunter πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 56 KB

## Abstract Manipulation of γ‐aminobutyrate (GABA) system has been little studied in Parkinson's disease, despite the fact that GABA subserves a large part of the basal ganglia, including the outflow tracts. To test whether antagonism of GABA could improve features of PD, we administered open label